Literature DB >> 24418172

Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients.

Domenico Galati1, Marina De Martino2, Annamaria Trotta3, Gaetano Rea4, Dario Bruzzese5, Gaetano Cicchitto6, Anna Agnese Stanziola2, Maria Napolitano3, Alessandro Sanduzzi2, Marialuisa Bocchino7.   

Abstract

The immune response plays an unsettled role in the pathogenesis of idiopathic pulmonary fibrosis (IPF), the contribution of inflammation being controversial as well. Emerging novel T cell sub-populations including regulatory T lymphocytes (Treg) and interleukin (IL)-17 secreting T helper cells (Th17) may exert antithetical actions in this scenario. Phenotype and frequency of circulating immune cell subsets were assessed by multi-parametric flow cytometry in 29 clinically stable IPF patients and 17 healthy controls. The interplay between Treg lymphocytes expressing transforming growth factor (TGF)-β and Th17 cells was also investigated. Proportion and absolute number of natural killer (NK) cells were significantly reduced in IPF patients in comparison with controls (p<0.001). Conversely, the proportion and absolute number of CD3(+)CD4(+)CD25(high)Foxp-3(+) cells were significantly increased in IPF patients (p=0.000). As in controls, almost the totality of cells (>90%) expressed TGF-β upon stimulation. Interestingly, the frequency of Th17 cells was significantly compromised in IPF patients (p=0.000) leading to an increased TGF-β/IL-17 ratio (4.2±2.3 vs 0.5±0.3 in controls, p=0.000). Depletion of NK and Th17 cells along with a not compromised Treg compartment delineate the existence of an "immune profile" that argue against the recent hypothesis of IPF as an autoimmune disease. Our findings along with the imbalance of the Treg/Th17 axis more closely suggest these immune perturbations to be similar to those observed in cancer. Clinical relevance, limitations and perspectives for future research are discussed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Flow cytometry; IPF; NK cells; Regulatory T cells; Th17 cells

Mesh:

Substances:

Year:  2014        PMID: 24418172     DOI: 10.1016/j.cyto.2013.12.003

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  31 in total

1.  Lactobacillus casei regulates differentiation of Th17/Treg cells to reduce intestinal inflammation in mice.

Authors:  Kai Wang; Hao Dong; Yu Qi; Zhihua Pei; Shushuai Yi; Xiaojie Yang; Yanli Zhao; Fanxing Meng; Shouping Yu; Tiezhong Zhou; Guixue Hu
Journal:  Can J Vet Res       Date:  2017-04       Impact factor: 1.310

2.  Regulatory T Cells in Idiopathic Pulmonary Fibrosis: Too Much of a Good Thing?

Authors:  Meagan W Moore; Erica L Herzog
Journal:  Am J Pathol       Date:  2016-06-23       Impact factor: 4.307

Review 3.  Natural killer cells in inflammatory heart disease.

Authors:  SuFey Ong; Noel R Rose; Daniela Čiháková
Journal:  Clin Immunol       Date:  2016-11-25       Impact factor: 3.969

4.  NK and NKT-like cells in granulomatous and fibrotic lung diseases.

Authors:  L Bergantini; P Cameli; M d'Alessandro; C Vagaggini; R M Refini; C Landi; M G Pieroni; M Spalletti; P Sestini; E Bargagli
Journal:  Clin Exp Med       Date:  2019-09-04       Impact factor: 3.984

5.  Activated human T lymphocytes inhibit TGFβ-induced fibroblast to myofibroblast differentiation via prostaglandins D2 and E2.

Authors:  Shannon H Lacy; Amali P Epa; Stephen J Pollock; Collynn F Woeller; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-20       Impact factor: 5.464

Review 6.  IL-17 in the lung: the good, the bad, and the ugly.

Authors:  Stephen J Gurczynski; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

7.  Caveolin-1 Promotes the Imbalance of Th17/Treg in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Nina Sun; Xiaofang Wei; Jingluan Wang; Zhaozhong Cheng; Weihong Sun
Journal:  Inflammation       Date:  2016-12       Impact factor: 4.092

8.  CD4(+)CD25(hi)Foxp3(+) Cells Exacerbate Bleomycin-Induced Pulmonary Fibrosis.

Authors:  Shirin Z Birjandi; Vyacheslav Palchevskiy; Ying Ying Xue; Stefanie Nunez; Rita Kern; S Sam Weigt; Joseph P Lynch; Talal A Chatila; John A Belperio
Journal:  Am J Pathol       Date:  2016-06-16       Impact factor: 4.307

Review 9.  Immune dysregulation as a driver of idiopathic pulmonary fibrosis.

Authors:  Kevin Shenderov; Samuel L Collins; Jonathan D Powell; Maureen R Horton
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 10.  Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis.

Authors:  Tanyalak Parimon; Miriam S Hohmann; Changfu Yao
Journal:  Int J Mol Sci       Date:  2021-06-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.